Aluminum ions stimulate the oxidizability of low density lipoprotein by Fe²⁺: Implication in hemodialysis mediated atherogenic LDL modification

References

• Oteiza PI, Fraga CG, Keen CL. Aluminum has both oxidant and antioxidant effects in mouse brain membranes. Arch Biochem Biophys 1993; 300: 517–521
   PubMedGoogle Scholar
• Quinlan GJ, Halliwell B, Moorhouse CP, Gutteridge JM. Action of lead(II) and aluminium(III) ions on iron-stimulated lipid peroxidation in liposomes, erythrocytes and rat liver microsomal fractions. Biochim Biophys Acta 1988; 962: 196–200
   PubMed Web of Science ®Google Scholar
• Verstraeten SV, Nogueira LV, Schreier S, Oteiza PI. Effect of trivalent metal ions on phase separation and membrane lipid packing: Role in lipid peroxidation. Arch Biochem Biophys 1997; 338: 121–127
   PubMed Web of Science ®Google Scholar
• Verstraeten SV, Oteiza PI. Sc3+, Ga3+, In3+, Y3+, and Be2+ promote changes in membrane physical properties and facilitate Fe2(+)-initiated lipid peroxidation. Arch Biochem Biophys 1995; 322: 284–290
   PubMed Web of Science ®Google Scholar
• Ward RJ, Zhang Y, Crichton RR. Aluminium toxicity and iron homeostasis. J Inorg Biochem 2001; 87: 9–14
   PubMed Web of Science ®Google Scholar
• Pratico D, Uryu K, Sung S, Tang S, Trojanowski JQ, Lee VM. Aluminum modulates brain amyloidosis through oxidative stress in APP transgenic mice. FASEB J 2002; 16: 1138–1140
   PubMed Web of Science ®Google Scholar
• Lee SH, Huang JW, Hung KY, Leu LJ, Kan YT, Yang CS, Chung WD, Huang CL, Chen PY, Chen JS, Chen WY. Trace metals' abnormalities in hemodialysis patients: Relationship with medications. Artif Organs 2000; 24: 841–844
   PubMedGoogle Scholar
• Christen Y. Oxidative stress and Alzheimer disease. Am J Clin Nutr 2000; 71: 621S–629S
   PubMed Web of Science ®Google Scholar
• Arlt S, Beisiegel U, Kontush A. Lipid peroxidation in neurodegeneration: New insights into Alzheimer's disease. Curr Opin Lipidol 2002; 13: 289–294
   PubMed Web of Science ®Google Scholar
• Neiva TJ, Benedetti AL, Tanaka SM, Santos JI, D'Amico EA. Determination of serum aluminum, platelet aggregation and lipid peroxidation in hemodialyzed patients. Braz J Med Biol Res 2002; 35: 345–350
   PubMed Web of Science ®Google Scholar
• Wratten ML, Tetta C, Ursini F, Sevanian A. Oxidant stress in hemodialysis: Prevention and treatment strategies. Kidney Int Suppl 2000; 76: S126–S132
   PubMedGoogle Scholar
• Lin TH, Chen JG, Liaw JM, Juang JG. Trace elements and lipid peroxidation in uremic patients on hemodialysis. Biol Trace Elem Res 1996; 51: 277–283
   PubMed Web of Science ®Google Scholar
• Lindner A, Charra B, Sherrard DJ, Scribner BH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974; 290: 697–701
   PubMed Web of Science ®Google Scholar
• Berliner JA, Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 1996; 20: 707–727
   PubMed Web of Science ®Google Scholar
• Esterbauer H, Wag G, Puhl H. Lipid peroxidation and its role in atherosclerosis. Br Med Bull 1993; 49: 566–576
   PubMed Web of Science ®Google Scholar
• Esterbauer H, Gebicki J, Puhl H, Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med 1992; 13: 341–390
   PubMed Web of Science ®Google Scholar
• Hermann M, Gmeiner B. Altered susceptibility to in vitro oxidation of LDL in LDL complexes and LDL aggregates. Arterioscler Thromb 1992; 12: 1503–1506
   PubMed Web of Science ®Google Scholar
• Dulley JR, Grieve PA. A simple technique for eliminating interference by detergents in the Lowry method of protein determination. Anal Biochem 1975; 64: 136–141
   PubMed Web of Science ®Google Scholar
• Exner M, Alt E, Hermann M, Hofbauer R, Kapiotis S, Quehenberger P, Speiser W, Minar E, Gmeiner B. p-Hydroxyphenylacetaldehyde, the major product of tyrosine oxidation by the activated myeloperoxidase system can act as an antioxidant in LDL. FEBS Lett 2001; 490: 28–31
   PubMedGoogle Scholar
• Kapiotis S, Besemer J, Bevec D, Valent P, Bettelheim P, Lechner K, Speiser W. Interleukin-4 counteracts pyrogen-induced downregulation of thrombomodulin in cultured human vascular endothelial cells. Blood 1991; 78: 410–415
   PubMed Web of Science ®Google Scholar
• Exner M, Hermann M, Hofbauer R, Hartmann B, Kapiotis S, Gmeiner B. Homocysteine promotes the LDL oxidase activity of ceruloplasmin. FEBS Lett 2002; 531: 402–406
   PubMed Web of Science ®Google Scholar
• Esterbauer H, Striegl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 1989; 6: 67–75
   PubMed Web of Science ®Google Scholar
• Exner M, Hermann M, Hofbauer R, Kapiotis S, Speiser W, Held I, Seelos C, Gmeiner BM. The salicylate metabolite gentisic acid, but not the parent drug, inhibits glucose autoxidation-mediated atherogenic modification of low density lipoprotein. FEBS Lett 2000; 470: 47–50
   PubMed Web of Science ®Google Scholar
• Parasassi T, Bittolo-Bon G, Brunelli R, Cazzolato G, Krasnowska EK, Mei G, Sevanian A, Ursini F. Loss of apoB-100 secondary structure and conformation in hydroperoxide rich, electronegative LDL( − ). Free Radic Biol Med 2001; 31: 82–89
   PubMedGoogle Scholar
• Dousset N, Ferretti G, Taus M, Valdiguie P, Curatola G. Fluorescence analysis of lipoprotein peroxidation. Methods Enzymol 1994; 233: 459–469
   PubMedGoogle Scholar
• Fish WW. Rapid colorimetric micromethod for the quantitation of complexed iron in biological samples. Methods Enzymol 1988; 158: 357–364
   PubMed Web of Science ®Google Scholar
• Thomas JP, Kalyanaraman B, Girotti AW. Involvement of preexisting lipid hydroperoxides in Cu(2+)-stimulated oxidation of low-density lipoprotein. Arch Biochem Biophys 1994; 315: 244–254
   PubMed Web of Science ®Google Scholar
• Darley-Usmar VM, Hogg N, O'Leary VJ, Wilson MT, Moncada S. The simultaneous generation of superoxide and nitric oxide can initiate lipid peroxidation in human low density lipoprotein. Free Radic Res Commun 1992; 17: 9–20
   PubMed Web of Science ®Google Scholar
• Gieseg SP, Pearson J, Firth CA. Protein hydroperoxides are a major product of low density lipoprotein oxidation during copper, peroxyl radical and macrophage-mediated oxidation. Free Radic Res 2003; 37: 983–991
   PubMed Web of Science ®Google Scholar
• Heinecke JW. Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis. Curr Opin Lipidol 1997; 8: 268–274
   PubMed Web of Science ®Google Scholar
• Camejo G, Halberg C, Manschik-Lundin A, Hurt-Camejo E, Rosengren B, Olsson H, Hansson GI, Forsberg GB, Ylhen B. Hemin binding and oxidation of lipoproteins in serum: Mechanisms and effect on the interaction of LDL with human macrophages. J Lipid Res 1998; 39: 755–766
   PubMedGoogle Scholar
• Balla G, Jacob HS, Eaton JW, Belcher JD, Vercellotti GM. Hemin: A possible physiological mediator of low density lipoprotein oxidation and endothelial injury. Arterioscler Thromb 1991; 11: 1700–1711
   PubMedGoogle Scholar
• Charytan C, Levin N, Al Saloum M, Hafeez T, Gagnon S, Van Wyck DB. Efficacy and safety of iron sucrose for iron deficiency in patients with dialysis-associated anemia: North American clinical trial. Am J Kidney Dis 2001; 37: 300–307
   PubMedGoogle Scholar
• Geisser P, Baer M, Schaub E. Structure/histotoxicity relationship of parenteral iron preparations. Arzneimittelforschung 1992; 42: 1439–1452
   PubMed Web of Science ®Google Scholar
• Camejo G, Hurt-Camejo E, Rosengren B, Wiklund O, Lopez F, Bondjers G. Modification of copper-catalyzed oxidation of low density lipoprotein by proteoglycans and glycosaminoglycans. J Lipid Res 1991; 32: 1983–1991
   PubMedGoogle Scholar
• Minami T, Ichii M, Tohno Y, Tohno S, Utsumi M, Yamada MO, Okazaki Y. Age-dependent aluminum accumulation in the human aorta and cerebral artery. Biol Trace Elem Res 1996; 55: 199–205
   PubMedGoogle Scholar
• Hazell LJ, Arnold L, Flowers D, Waeg G, Malle E, Stocker R. Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J Clin Invest 1996; 97: 1535–1544
   PubMed Web of Science ®Google Scholar
• Fabjan JS, Abuja PM, Schaur RJ, Sevanian A. Hypochlorite induces the formation of LDL( − ), a potentially atherogenic low density lipoprotein subspecies. FEBS Lett 2001; 499: 69–72
   PubMed Web of Science ®Google Scholar
• Wagner P, Heinecke JW. Copper ions promote peroxidation of low density lipoprotein lipid by binding to histidine residues of apolipoprotein B100, but they are reduced at other sites on LDL. Arterioscler Thromb Vasc Biol 1997; 17: 3338–3346
   PubMed Web of Science ®Google Scholar
• Dousset N, Ferretti G, Galeazzi T, Taus M, Gouaze V, Berthon G, Curatola G. Effect of aluminium ions on liposomal membranes as detected by Laurdan fluorescence. Free Radic Res 1997; 27: 291–299
   PubMed Web of Science ®Google Scholar
• Exley C. The pro-oxidant activity of aluminum. Free Radic Biol Med 2004; 36: 380–387
   PubMed Web of Science ®Google Scholar
• Sengoelge G, Rainer V, Kletzmayr J, Jansen M, Derfler K, Fodinger M, Horl WH, Sunder-Plassmann G. Dose-dependent effect of parenteral iron therapy on bleomycin-detectable iron in immune apheresis patients. Kidney Int 2004; 66: 295–302
   PubMedGoogle Scholar
• Banyai S, Rainer V, Derfler K, Druml W, Horl H, Sunder-Plassmann G. Bleomycin detectable free iron (BDI) is present in patients on intravenous (IV) iron therapy. J Am Soc Nephrol 1998; 9
   Google Scholar
• Zager RA, Johnson AC, Hanson SY. Parenteral iron nephrotoxicity: Potential mechanisms and consequences. Kidney Int 2004; 66: 144–156
   PubMed Web of Science ®Google Scholar
• Agarwal R, Vasavada N, Sachs NG, Chase S. Oxidative stress and renal injury with intravenous iron in patients with chronic kidney disease. Kidney Int 2004; 65: 2279–2289
   PubMed Web of Science ®Google Scholar
• Zager RA, Johnson AC, Hanson SY, Wasse H. Parenteral iron formulations: A comparative toxicologic analysis and mechanisms of cell injury. Am J Kidney Dis 2002; 40: 90–103
   PubMed Web of Science ®Google Scholar